Philip Privitera to Humans
This is a "connection" page, showing publications Philip Privitera has written about Humans.
Connection Strength
0.005
-
Utilization of a radioimmunoassay to detect the generation of Arg-Pro-Pro-Gly-Phe, a stable endproduct of bradykinin metabolism (from cultured rat aortic smooth muscle cells exposed to bradykinin). Int Immunopharmacol. 2002 Dec; 2(13-14):1995-2003.
Score: 0.002
-
Orthostatic hypotension with brainstem tumors. Neurology. 1984 Sep; 34(9):1137-43.
Score: 0.001
-
Time course of development of the antihypertensive effect of propranolol. Hypertension. 1983 Nov-Dec; 5(6):852-7.
Score: 0.001
-
Childhood familial and racial differences in physiologic and biochemical factors related to hypertension. Hypertension. 1983 Jan-Feb; 5(1):56-70.
Score: 0.001
-
Cardiovascular effects of a 4'-methylthio analog of propranolol. J Pharmacol Exp Ther. 1981 Dec; 219(3):685-90.
Score: 0.000
-
Bartter's syndrome: urinary prostaglandin E-like material and kallikrein; indomethacin effects. Ann Intern Med. 1977 Sep; 87(3):281-6.
Score: 0.000
-
The importance of stable isotope labelled drugs in clinical pharmacology: with illustrations from studies on the disposition of propranolol and nortriptyline in man. South Med J. 1974 Aug; 67(8):990-1002.
Score: 0.000
-
Effect of methyldopa on plasma renin activity in man. Circ Res. 1969 Nov; 25(5):543-8.
Score: 0.000